Halberd Entering the Medical Metaverse

2 years ago

Jackson Center, Pennsylvania--(Newsfile Corp. - April 11, 2022) - Halberd Corporation (OTC PINK: HALB) announces plans to enter the Metaverse…

Research: Chronic Data Readiness Issues Impeding Digital Transformation in Healthcare

2 years ago

New research finds healthcare leaders have high aspirations for digital transformation, but a lack of data readiness threatens their ability…

Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest

2 years ago

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the…

TRUVIC Announces 510(k) Clearance for the Prodigy™ Thrombectomy System

2 years ago

First regulatory milestone as part of a strategy to advance patient care CAMPBELL, Calif.--(BUSINESS WIRE)--Truvic Medical, Inc., a wholly owned…

Equideum Health and Nokia Bell Labs Collaborate to Empower Individuals to Own and Benefit from Health Data Sourced from Edge Devices

2 years ago

Equideum Health and Nokia Bell Labs are collaborating with a focus on integrating and leveraging edge datasets to be made…

Chairman W. Stancil Starnes to Retire From ProAssurance Board of Directors

2 years ago

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) today announced that W. Stancil (Stan) Starnes, Executive Chairman of the Board of Directors, will…

Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf (UKE) Opens New Avenues for Personalized Medicine in COVID-19

2 years ago

A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.The…

Notice to Annual General Meeting of Spago Nanomedical AB (publ)

2 years ago

LUND, SWEDEN / ACCESSWIRE / April 11, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)The shareholders of Spago Nanomedical AB (publ), corporate registration…

AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member

2 years ago

PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a…

Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting

2 years ago

- Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and duration of response compared to…